Alnylam Pharmaceuticals, Inc. (ALNY) — Analyst estimates
Consensus analyst estimates for Alnylam Pharmaceuticals, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 1.64B | 2.33 | 4 |
| 2027 | 2.12B | 3.12 | 4 |
| 2028 | 2.31B | 3.7 | 5 |
| 2029 | 10.16B | 15.83 | 10 |
| 2030 | 11.74B | 19.51 | 6 |
Consensus analyst estimates by fiscal year.